{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:48:03Z","timestamp":1790563683363,"version":"4.1.0"},"reference-count":273,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Although significant progress has been made in medicine and antimicrobial research, viral infections continue to pose a critical global health challenge, particularly when they involve the central nervous system (CNS). Despite advances in vaccines, antiviral agents, and small molecule therapeutics, current strategies remain insufficient to address the complex consequences of many CNS infections fully. Notably, many viruses are neurotropic and can invade the CNS, triggering infectious neuroinflammation that often lead to chronic neurological disorders and lasting morbidity. Current therapeutic approaches are largely ineffective in preventing or reversing this long-term neurological damage, underscoring the urgent need for innovative prophylactic and therapeutic interventions. Mesenchymal stem cells (MSCs) have emerged as a promising strategy to counteract chronic neuroinflammation and promote tissue repair following viral CNS infections. This review provides a comprehensive overview of CNS viral infection and neuroinflammation, including epidemiology and pathophysiology, and critically examines the limitations of existing treatments, particularly their inability to mitigate persistent neurological sequelae. Furthermore, we summarize recent preclinical and clinical studies investigating the use of MSCs in the context of CNS viral infections, highlighting their immunomodulatory and neuroprotective mechanisms, and discuss the challenges and future directions for MSC-based therapies in clinical settings.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1677433","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:29:39Z","timestamp":1761715779000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-based strategies for treating neuroinflammation and promoting tissue repair"],"prefix":"10.3389","volume":"16","author":[{"given":"Javier","family":"Carbone-Schellman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javiera","family":"Fontecilla-Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Sales-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Chaparro-Pico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Molina-Berr\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Celeste","family":"Ruete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra A.","family":"Machuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma. Cecilia","family":"Opazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo E.","family":"Ezquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa F.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/v16050787","article-title":"Square the circle: diversity of viral pathogens causing neuro-infectious diseases","volume":"16","author":"Nurmukanova","year":"2024","journal-title":"Viruses"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00276","article-title":"Neuroinflammation and infection: molecular mechanisms associated with dysfunction of neurovascular unit","volume":"7","author":"Tohidpour","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.04.012","article-title":"Immunological defense of CNS barriers against infections","volume":"55","author":"Ampie","year":"2022","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00118-13","article-title":"Pathogens penetrating the central nervous system: Infection pathways and the cellular and molecular mechanisms of invasion","volume":"27","author":"Dando","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2022.04.026","article-title":"Global magnitude of encephalitis burden and its evolving pattern over the past 30 years","volume":"84","author":"Wang","year":"2022","journal-title":"J Infect"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint16050073","article-title":"The clinical manifestations, risk factors, etiologies, and outcomes of adult patients with infectious meningitis and encephalitis: single center experience","volume":"16","author":"Makkawi","year":"2024","journal-title":"Neurol Int"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.06.003","article-title":"The potential role of HIV-1 latency in promoting neuroinflammation and HIV-1-associated neurocognitive disorder","volume":"43","author":"Sreeram","year":"2022","journal-title":"Trends Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/vaccines11020325","article-title":"Insights into the Novel Therapeutics and Vaccines against Herpes Simplex Virus","volume":"11","author":"Malik","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npz007","article-title":"Outcomes with acyclovir treatment in herpes simplex encephalitis after surgery for solid CNS tumors: A case report and systematic review of the literature","volume":"6","author":"Yari","year":"2019","journal-title":"Neuro Oncol Pract"},{"key":"B10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s13287-024-04076-6","article-title":"Extracellular vesicles from mesenchymal stem cells improve neuroinflammation and neurotransmission in hippocampus and cognitive impairment in rats with mild liver damage and minimal hepatic encephalopathy","volume":"15","author":"Mincheva","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.3390\/ijms22094853","article-title":"Stem cell therapy for modulating neuroinflammation in neuropathic pain","volume":"22","author":"Joshi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10571-024-01460-x","article-title":"A new strategy for the regulation of neuroinflammation: exosomes derived from mesenchymal stem cells","volume":"44","author":"Ge","year":"2024","journal-title":"Cell Mol Neurobiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216040","article-title":"Mesenchymal stem cells in the pathogenesis and therapy of autoimmune and autoinflammatory diseases","volume":"24","author":"Zaripova","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-022-02944-7","article-title":"Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19","volume":"13","author":"Yasamineh","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196311","article-title":"Mesenchymal stem cell therapy in multiple sclerosis: A systematic review and meta-analysis","volume":"12","author":"Islam","year":"2023","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/cells13090779","article-title":"Mesenchymal stem cells and their role in neurodegenerative diseases","volume":"13","author":"Mattei","year":"2024","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00147-24","article-title":"Tackling cutaneous herpes simplex virus disease with topical immunomodulators\u2014a call to action","volume":"38","author":"Duarte","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662234","article-title":"Crosstalk between epithelial cells, neurons and immune mediators in HSV-1 skin infection","volume":"12","author":"Duarte","year":"2021","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00046","article-title":"Herpes simplex virus type 1 infection of the central nervous system: Insights into proposed interrelationships with neurodegenerative disorders","volume":"13","author":"Duarte","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.6417","article-title":"Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis","volume":"181","author":"Marques","year":"2008","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/1742-2094-9-270","article-title":"Inflammatory monocytes and the pathogenesis of viral encephalitis","volume":"9","author":"Terry","year":"2012","journal-title":"J Neuroinflamm"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2020.03.003","article-title":"Herpes simplex virus-1 in the brain: the dark side of a sneaky infection","volume":"28","author":"Marcocci","year":"2020","journal-title":"Trends Microbiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-018-9772-5","article-title":"Insights into the pathogenesis of herpes simplex encephalitis from mouse models","volume":"29","author":"Mancini","year":"2018","journal-title":"Mamm Genome"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/13550280152403254","article-title":"Robust expression of TNF-\u03b1, IL-1\u03b2, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus","volume":"7","author":"Lokensgard","year":"2001","journal-title":"J Neurovirol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.658695","article-title":"The potential role of herpes simplex virus type 1 and neuroinflammation in the pathogenesis of Alzheimer\u2019s disease","volume":"12","author":"Laval","year":"2021","journal-title":"Front Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.635257","article-title":"Asymptomatic herpes simplex virus type 1 infection causes an earlier onset and more severe experimental autoimmune encephalomyelitis","volume":"12","author":"Duarte","year":"2021","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2022.105084","article-title":"Is there a role for herpes simplex virus type 1 in multiple sclerosis","volume":"25","author":"Duarte","year":"2023","journal-title":"Microbes Infect"},{"key":"B28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s42003-024-06486-x","article-title":"Asymptomatic herpes simplex virus brain infection elicits cellular senescence phenotypes in the central nervous system of mice suffering multiple sclerosis-like disease","volume":"7","author":"Duarte","year":"2024","journal-title":"Commun Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.01.003","article-title":"Novel insights to enhance therapeutics with acyclovir in the management of herpes simplex encephalitis","volume":"110","author":"Gurgel Assis","year":"2021","journal-title":"J Pharm Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00139","article-title":"Current antivirals and novel botanical molecules interfering with herpes simplex virus infection","volume":"11","author":"\u00c1lvarez","year":"2020","journal-title":"Front Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112921","article-title":"The role of glucocorticoids in inflammatory diseases","volume":"10","author":"Reichardt","year":"2021","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad474","article-title":"Unintended consequences: risk of opportunistic infections associated with long-term glucocorticoid therapies in adults","volume":"78","author":"Chastain","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2021.1980990","article-title":"Herpes simplex virus interference with immunity: Focus on dendritic cells","volume":"12","author":"Far\u00edas","year":"2021","journal-title":"Virulence"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112441","article-title":"HSV-1 alters lipid metabolism and induces lipid droplet accumulation in functionally impaired mouse dendritic cells","volume":"28","author":"Far\u00edas","year":"2025","journal-title":"iScience"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708955","article-title":"IL-10-dependent amelioration of chronic inflammatory disease by microdose subcutaneous delivery of a prototypic immunoregulatory small molecule","volume":"12","author":"Tabares-Guevara","year":"2021","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12061170","article-title":"Heme oxygenase-1 expression in dendritic cells contributes to protective immunity against herpes simplex virus skin infection","volume":"12","author":"Tognarelli","year":"2023","journal-title":"Antioxidants"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.764861","article-title":"Pharmacological inhibition of IRE-1 alpha activity in herpes simplex virus type 1 and type 2-infected dendritic cells enhances T cell activation","volume":"12","author":"Tognarelli","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Sci (1979)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.764937","article-title":"Primary peripheral Epstein-Barr virus infection can lead to CNS infection and neuroinflammation in a rabbit model: implications for multiple sclerosis pathogenesis","volume":"12","author":"Hassani","year":"2021","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7945","article-title":"Unpacking the CNS manifestations of Epstein-Barr virus: an imaging perspective","volume":"44","author":"Soni","year":"2023","journal-title":"Am J Neuroradiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/pathogens7030059","article-title":"Contribution of Epstein\u2013Barr virus latent proteins to the pathogenesis of classical hodgkin lymphoma","volume":"7","author":"Vrzalikova","year":"2018","journal-title":"Pathogens"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00211","article-title":"Epstein-barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: An update","volume":"8","author":"Smatti","year":"2018","journal-title":"Front Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.816098","article-title":"Epstein-Barr virus and neurological diseases","volume":"8","author":"Zhang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106507","article-title":"Clinical significance of Epstein-Barr virus in the cerebrospinal fluid of immunocompetent patients","volume":"202","author":"Lee","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-011-1261-7","article-title":"Expanding the spectrum of neurological disease associated with Epstein-Barr virus activity","volume":"30","author":"Kleines","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10321","article-title":"Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system","volume":"52","author":"Weinberg","year":"2002","journal-title":"Ann Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e01844-15","DOI":"10.1128\/mBio.02981-20","article-title":"Erratum: Gammaherpesvirus infection of human neuronal cells (mBio, (2015) 6(6), e01844-15, 10.1128\/mBio.01844-15)","volume":"12","author":"Jha","year":"2021","journal-title":"mBio"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1108212","article-title":"Viral-induced neuroinflammation: Different mechanisms converging to similar exacerbated glial responses","volume":"17","author":"Rocamonde","year":"2023","journal-title":"Front Neurosci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.1c00584","article-title":"Indication of neurodegenerative cascade initiation by amyloid-like aggregate-forming EBV proteins and peptide in Alzheimer\u2019s disease","volume":"12","author":"Tiwari","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1895-7","article-title":"Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease","volume":"577","author":"Gate","year":"2020","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000239","article-title":"Human serum antibodies against EBV latent membrane protein 1 cross-react with a-synuclein","volume":"3","author":"Woulfe","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.9.1398","article-title":"Monoclonal antibodies against Epstein-Barr virus cross-react with \u03b1-synuclein in human brain","volume":"55","author":"Woulfe","year":"2000","journal-title":"Neurology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103087","article-title":"Probing the association between Multiple Sclerosis and Epstein Barr Virus from a therapeutic perspective","volume":"52","author":"Drosu","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511408991","article-title":"Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: A prospective study among United States military personnel","volume":"17","author":"Munger","year":"2011","journal-title":"Multiple Sclerosis J"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.652811","article-title":"Sustained clinical improvement in a subset of patients with progressive multiple sclerosis treated with Epstein\u2013Barr virus-specific T cell therapy","volume":"12","author":"Ioannides","year":"2021","journal-title":"Front Neurol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.1993.11718310","article-title":"Cimetidine is not more effective than placebo in acute infectious mononucleosis","volume":"48","author":"Knockaert","year":"1993","journal-title":"Acta Clin Belg"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00113-16","article-title":"Valpromide inhibits Lytic cycle reactivation of epstein-Barr virus","volume":"7","author":"Gorres","year":"2016","journal-title":"mBio"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11167","article-title":"Multiple sclerosis and subsequent human immunodeficiency virus infection: A case with the rare comorbidity, focus on novel treatment issues and review of the literature","volume":"31","author":"Charalampos","year":"2018","journal-title":"In Vivo (Brooklyn)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41419-018-0789-1","article-title":"BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc article","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.751644","article-title":"Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps","volume":"292","author":"Keck","year":"2017","journal-title":"J Biol Chem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/v16010124","article-title":"Update of natural products and their derivatives targeting Epstein\u2013Barr infection","volume":"16","author":"Pennisi","year":"2024","journal-title":"Viruses"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158155","article-title":"Comprehensive review of COVID-19: epidemiology, pathogenesis, advancement in diagnostic and detection techniques, and post-pandemic treatment strategies","volume":"25","author":"Chung","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38194","article-title":"Review of neurological manifestations of SARS-CoV-2","volume":"15","author":"Priyal","year":"2023","journal-title":"Cureus"},{"key":"B64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3892\/etm.2022.11290","article-title":"Long COVID and neuropsychiatric manifestations (Review)","volume":"23","author":"Efstathiou","year":"2022","journal-title":"Exp Ther Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-021-00978-8","article-title":"Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19","volume":"46","author":"Jaywant","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100484","article-title":"Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study","volume":"25","author":"Lu","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21203\/rs.3.rs-1031824\/v1","article-title":"COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis","author":"Klein","year":"2021","journal-title":"Res Sq"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01896-0","article-title":"Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports","volume":"17","author":"Najjar","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: a post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000821","article-title":"Increased CSF levels of IL-1\u03b2, IL-6, and ACE in SARS-CoV-2\u2013associated encephalitis","volume":"7","author":"Bodro","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nature16999","article-title":"Erratum: Structural and functional features of central nervous system lymphatic vessels (Nature (2015) 523 (337-341) DOI: 10.1038\/nature14432)","volume":"533","author":"Louveau","year":"2016","journal-title":"Nature"},{"key":"B72","article-title":"Blood\u2013brain barrier: Covid-19, pandemics, and cytokine norms","volume":"18","author":"Yarlagadda","year":"2021","journal-title":"Innov Clin Neurosci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"113167","DOI":"10.1016\/j.isci.2025.113167","article-title":"Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine","volume":"28","author":"Mart\u00ednez-Balboa","year":"2025","journal-title":"iScience"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad320","article-title":"Differential severe acute respiratory syndrome coronavirus 2\u2013specific humoral response in inactivated virus\u2013vaccinated, convalescent, and breakthrough-infected subjects","volume":"228","author":"Duarte","year":"2023","journal-title":"J Infect Dis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01311-22","article-title":"Inactivated vaccine-induced SARS-CoV-2 variant-specific immunity in children","volume":"13","author":"Soto","year":"2022","journal-title":"mBio"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01423-22","article-title":"A booster dose of CoronaVac increases neutralizing antibodies and T cells that recognize delta and omicron variants of concern","volume":"13","author":"Schultz","year":"2022","journal-title":"mBio"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81477","article-title":"Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial","volume":"11","author":"G\u00e1lvez","year":"2022","journal-title":"Elife"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104563","article-title":"Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults","volume":"91","author":"M\u00e9ndez","year":"2023","journal-title":"EBioMedicine"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.10.024","article-title":"Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients","volume":"15","author":"Sarhan","year":"2022","journal-title":"J Infect Public Health"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214462","article-title":"Therapeutic efficacy and outcomes of remdesivir versus remdesivir with tocilizumab in severe SARS-CoV-2 infection","volume":"23","author":"Vulturar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1129459","article-title":"Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative","volume":"14","author":"Bonilla","year":"2023","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00464-z","article-title":"Author correction: HIV infection (Nature reviews disease primers, (2023), 9, 1, (42), 10.1038\/s41572-023-00452-3)","volume":"9","author":"Bekker","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12063","article-title":"HIV and co-infections","volume":"254","author":"Chang","year":"2013","journal-title":"Immunol Rev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J Neurovirol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00953-5","article-title":"Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection","volume":"44","author":"Killingsworth","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2519","article-title":"The relationship between HIV-1 neuroinflammation, neurocognitive impairment and encephalitis pathology: A systematic review of studies investigating post-mortem brain tissue","volume":"34","author":"Williams","year":"2024","journal-title":"Rev Med Virol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-262","article-title":"Platelet-derived growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: Implications for HIV-associated neuroinflammation","volume":"9","author":"Bethel-Brown","year":"2012","journal-title":"J Neuroinflamm"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.6.1703","article-title":"Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease","volume":"176","author":"Genis","year":"1992","journal-title":"J Exp Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.8.4265","article-title":"Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l -cysteine","volume":"164","author":"Yeh","year":"2000","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J Neurosci"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1476810","article-title":"HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy","volume":"14","author":"Thangaraj","year":"2018","journal-title":"Autophagy"},{"key":"B93","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/jcm12030770","article-title":"CD8 encephalitis in HIV: A review of this emerging entity","volume":"12","author":"Shenoy","year":"2023","journal-title":"J Clin Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e32834695fb","article-title":"Current understanding of HIV-associated neurocognitive disorders pathogenesis","volume":"24","author":"Gannon","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812153192404","article-title":"Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex","volume":"319","author":"Schmitt","year":"1988","journal-title":"New Engl J Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200405010-00003","article-title":"Highly active antiretroviral therapy improves neurocognitive functioning","volume":"36","author":"Robertson","year":"2004","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002484","article-title":"Cognitive and neuronal link with inflammation: A longitudinal study in people with and without HIV infection","volume":"85","author":"Anderson","year":"2020","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2021.0230","article-title":"Human T cell lymphotropic virus type 1 global prevalence associated with the human development index: systematic review with meta-analysis","volume":"39","author":"Sampaio","year":"2023","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.2222\/jsv.36.195","article-title":"Transmission of ATLV (HTLV-I) through blood transfusion","volume":"36","author":"Okochi","year":"1986","journal-title":"Uirusu J Virol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199606010-00014","article-title":"Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group","volume":"12","author":"Kaplan","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.87.152","article-title":"Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): The ATL prevention program nagasaki","volume":"87","author":"Hino","year":"2011","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.2741\/3300","article-title":"Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease","volume":"14","author":"Lepoutre","year":"2009","journal-title":"Front Biosci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107669","article-title":"An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) focusing on clinical and laboratory biomarkers","volume":"218","author":"Yamauchi","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"327","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"326","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Sci (1979)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1038\/NRDP.2015.23","article-title":"CORRIGENDUM to: HTLV-1-associated myelopathy\/tropical spastic paraparesis (Nat. Rev. Dis. Primers, 15012; 10.1038\/nrdp.2015.12)","volume":"1","author":"Bangham","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B109","doi-asserted-by":"publisher","first-page":"11118","DOI":"10.1038\/s41598-018-29391-w","article-title":"Inhibition of tunneling nanotube (TNT) formation and human T-cell leukemia virus type 1 (HTLV-1) transmission by cytarabine","volume":"8","author":"Omsland","year":"2018","journal-title":"Sci Rep"},{"key":"B110","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12985-021-01643-8","article-title":"Decoding pathogenesis factors involved in the progression of ATLL or HAM\/TSP after infection by HTLV-1 through a systems virology study","volume":"18","author":"Zarei Ghobadi","year":"2021","journal-title":"Virol J"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.173738","article-title":"HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1\u2013associated myelopathy","volume":"9","author":"Maher","year":"2024","journal-title":"JCI Insight"},{"key":"B112","article-title":"HTLV-I-associated myelopathy: Acute progression and atypical MR findings","volume":"20","author":"Shakudo","year":"1999","journal-title":"Am J Neuroradiol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000832","article-title":"Management of HAM\/TSP: systematic review and consensus-based recommendations 2019","volume":"11","author":"Araujo","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"B114","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/pathogens9050342","article-title":"Antiretroviral therapy in HTLV-1 infection: An updated overview","volume":"9","author":"Marino-Merlo","year":"2020","journal-title":"Pathogens"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.6.933","article-title":"Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III\/lymphadenopathy-associated virus by 3\u2019-azido-3\u2019-deoxythymidine in vitro","volume":"30","author":"Nakashima","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113085","article-title":"Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I","volume":"80","author":"Matsushita","year":"1987","journal-title":"J Clin Invest"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(90)90172-6","article-title":"Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits","volume":"14","author":"Isono","year":"1990","journal-title":"Leuk Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.43.10.2125","article-title":"High-dose zidovudine induction in HTLV-I-associated myelopathy","volume":"43","author":"Sheremata","year":"1993","journal-title":"Neurology"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/BF00315691","article-title":"The effect of zidovudine on chronic myelopathy associated with HTLV-1","volume":"238","author":"Gout","year":"1991","journal-title":"J Neurol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.7.3891-3894.1991","article-title":"Equine H7N7 influenza A viruses are highly pathogenic in mice without adaptation: potential use as an animal model","volume":"65","author":"Kawaoka","year":"1991","journal-title":"J Virol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2005.09.001","article-title":"Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia\/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitro","volume":"68","author":"Balestrieri","year":"2005","journal-title":"Antiviral Res"},{"key":"B122","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1742-4690-3-63","article-title":"Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-l-associated myelopathy: A randomised trial","volume":"3","author":"Taylor","year":"2006","journal-title":"Retrovirology"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0446-y","article-title":"The emergence of Zika virus and its new clinical syndromes","volume":"560","author":"Pierson","year":"2018","journal-title":"Nature"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix515","article-title":"Zika virus structure, maturation, and receptors","volume":"216","author":"Sirohi","year":"2017","journal-title":"J Infect Dis"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1056\/nejmsr1604338","article-title":"Zika virus and birth defects \u2014 Reviewing the evidence for causality","volume":"374","author":"Rasmussen","year":"2016","journal-title":"New Engl J Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30318-8","article-title":"Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study","volume":"16","author":"de Ara\u00fajo","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.4103\/2096-2924.278679","article-title":"Single-cell RNA expression profiling of ACE2 and AXL in the human maternal-Fetal interface","volume":"4","author":"Zheng","year":"2020","journal-title":"Reprod Dev Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13578-016-0110-x","article-title":"Bioinformatic analysis reveals the expression of unique transcriptomic signatures in Zika virus infected human neural stem cells","volume":"6","author":"Rolfe","year":"2016","journal-title":"Cell Biosci"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix511","article-title":"Neurological implications of zika virus infection in adults","volume":"216","author":"Mu\u00f1oz","year":"2017","journal-title":"J Infect Dis"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17765-5","article-title":"In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus","volume":"8","author":"Azevedo","year":"2018","journal-title":"Sci Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.02.003","article-title":"Necroptosis: the release of damage-associated molecular patterns and its physiological relevance","volume":"38","author":"Kaczmarek","year":"2013","journal-title":"Immunity"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02557","article-title":"Zika virus infects, activates, and crosses brain microvascular endothelial cells, without barrier disruption","volume":"8","author":"Papa","year":"2017","journal-title":"Front Microbiol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw878","article-title":"Zika virus infects human fetal brain microglia and induces inflammation","volume":"64","author":"Lum","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B134","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/vaccines11040742","article-title":"Japanese encephalitis virus: an update on the potential antivirals and vaccines","volume":"11","author":"Srivastava","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51027","article-title":"Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015","volume":"9","author":"Quan","year":"2020","journal-title":"Elife"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638694","article-title":"Japanese encephalitis virus infected human monocyte-derived dendritic cells activate a transcriptional network leading to an antiviral inflammatory response","volume":"12","author":"Chauhan","year":"2021","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00143-15","article-title":"Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection","volume":"89","author":"Li","year":"2015","journal-title":"J Virol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.01.012","article-title":"DHA attenuated Japanese Encephalitis virus infection-induced neuroinflammation and neuronal cell death in cultured rat Neuron\/glia","volume":"93","author":"Chang","year":"2021","journal-title":"Brain Behav Immun"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-024-01212-z","article-title":"Role of inflammatory cytokine burst in neuro-invasion of Japanese Encephalitis virus infection: an immunotherapeutic approaches","volume":"30","author":"Ahmad","year":"2024","journal-title":"J Neurovirol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-49-7-607","article-title":"Secretion of the chemokine interleukin-8 during Japanese encephalitis virus infection","volume":"49","author":"Singh","year":"2000","journal-title":"J Med Microbiol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.11.070","article-title":"Induction of IP-10 (CXCL10) in astrocytes following Japanese encephalitis","volume":"414","author":"Bhowmick","year":"2007","journal-title":"Neurosci Lett"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1991.tb05813.x","article-title":"Neutrophil chemotactic factor produced by Japanese encephalitis virus stimulated macrophages","volume":"86","author":"Khanna","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.77.528","article-title":"Long-term disability from acute childhood Japanese encephalitis in Shanghai, China","volume":"77","author":"Ding","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.14-0148","article-title":"Neurological sequelae of hospitalized Japanese encephalitis cases in Gansu Province, China","volume":"92","author":"Yin","year":"2015","journal-title":"Am Soc Trop Med Hyg"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1155\/tbed\/9880670","article-title":"Scoping review of Japanese encephalitis virus transmission models","volume":"2025","author":"Laidlow","year":"2025","journal-title":"Transbound Emerg Dis"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14579","article-title":"Management of Japanese encephalitis: A current update","volume":"13","author":"Ajibowo","year":"2021","journal-title":"Cureus"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.17511\/ijpr.2016.i05.18","article-title":"Minocycline trial in Japanese encephalitis: a double blind, randomized placebo study","volume":"3","author":"Singh","year":"2016","journal-title":"Pediatr Rev: Int J Pediatr Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss","year":"2017","journal-title":"Lancet"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00758-24","article-title":"What\u2019s going on with measles","volume":"98","author":"Moss","year":"2024","journal-title":"J Virol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6830","article-title":"Measles: 142\u2009000 people died in 2018, mostly aged under 5","volume":"367","author":"Mahase","year":"2019","journal-title":"BMJ"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2025.101207","article-title":"Subacute sclerosing panencephalitis","volume":"54","author":"Gunasekaran","year":"2025","journal-title":"Semin Pediatr Neurol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.944436","article-title":"A review of the resurgence of measles, a vaccine-preventable disease, as current concerns contrast with past hopes for measles elimination","volume":"30","author":"Parums","year":"2024","journal-title":"Med Sci Monit"},{"key":"B153","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11940-022-00710-x","article-title":"Options in the treatment of subacute sclerosing panencephalitis: implications for low resource areas","volume":"24","author":"Samia","year":"2022","journal-title":"Curr Treat Options Neurol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e232408","DOI":"10.1136\/bcr-2019-232408","article-title":"Complications of measles: a case series","volume":"13","author":"Xerri","year":"2020","journal-title":"BMJ Case Rep"},{"key":"B155","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13287-017-0486-5","article-title":"Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality","volume":"8","author":"Bian","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050467","article-title":"Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome","volume":"8","author":"Harrell","year":"2019","journal-title":"Cells"},{"key":"B157","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/biom14050538","article-title":"MSC-based cell therapy in neurological diseases: A concise review of the literature in pre-clinical and clinical research","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1681","article-title":"Concise review: The surface markers and identity of human mesenchymal stem cells","volume":"32","author":"Lv","year":"2014","journal-title":"Stem Cells"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.5581\/1516-8484.20130017","article-title":"Immunological characteristics of mesenchymal stem cells","volume":"35","author":"de Vasconcellos MaChado","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091852","article-title":"Mesenchymal stem cell secretome: Toward cell-free therapeutic strategies in regenerative medicine","volume":"18","author":"Vizoso","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.11.099","article-title":"Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives","volume":"109","author":"Harrell","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61167-z","article-title":"A comparative analysis of multipotent mesenchymal stromal cells derived from different sources, with a focus on neuroregenerative potential","volume":"10","author":"Petrenko","year":"2020","journal-title":"Sci Rep"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2021.03.003","article-title":"Mesenchymal stem cells: Biological characteristics and application in disease therapy","volume":"185","author":"Lou","year":"2021","journal-title":"Biochimie"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2018_306","article-title":"Molecular mechanisms responsible for anti-inflammatory and immunosuppressive effects of mesenchymal stem cell-derived factors","volume":"1084","author":"Harrell","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010249","article-title":"Modulation of mesenchymal stem cells for enhanced therapeutic utility in ischemic vascular diseases","volume":"23","author":"Elshaer","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231710023","article-title":"Immunomodulatory mechanisms of mesenchymal stem cells and their potential clinical applications","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B168","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10571-025-01540-6","article-title":"Targeting neuroinflammation in preterm white matter injury: therapeutic potential of mesenchymal stem cell-derived exosomes","volume":"45","author":"Zhang","year":"2025","journal-title":"Cell Mol Neurobiol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12967-021-02822-5","article-title":"Chemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cells","volume":"19","author":"Cuesta-Gomez","year":"2021","journal-title":"J Transl Med"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1010399","article-title":"Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells","volume":"13","author":"Sarsenova","year":"2022","journal-title":"Front Immunol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13287-020-01920-3","article-title":"Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application","volume":"11","author":"Lee","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073397","article-title":"Strategies to potentiate paracrine therapeutic efficacy of mesenchymal stem cells in inflammatory diseases","volume":"22","author":"Seo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031365","article-title":"The therapeutic mechanisms of mesenchymal stem cells in MS\u2014A review focusing on neuroprotective properties","volume":"25","author":"Gavasso","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1472679","article-title":"Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond","volume":"16","author":"Yarahmadi","year":"2025","journal-title":"Front Neurol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3390\/cells13070617","article-title":"Mesenchymal-stem-cell-based therapy against gliomas","volume":"13","author":"Santill\u00e1n-Guaj\u00e1n","year":"2024","journal-title":"Cells"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.7150\/thno.81860","article-title":"Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer\u2019s disease","volume":"13","author":"Yin","year":"2023","journal-title":"Theranostics"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073829","article-title":"Mesenchymal stem cell-derived extracellular vesicles and their therapeutic use in central nervous system demyelinating disorders","volume":"23","author":"Allegretta","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B178","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13287-020-02091-x","article-title":"Exosomal microRNA-22-3p alleviates cerebral ischemic injury by modulating KDM6B\/BMP2\/BMF axis","volume":"12","author":"Zhang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B179","doi-asserted-by":"publisher","first-page":"11592","DOI":"10.1038\/s41598-017-11510-8","article-title":"Systematic review and meta-analysis of differentially expressed miRNAs in experimental and human temporal lobe epilepsy","volume":"7","author":"Korotkov","year":"2017","journal-title":"Sci Rep"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213377","article-title":"Emerging role of miR-21-5p in neuron\u2013glia dysregulation and exosome transfer using multiple models of Alzheimer\u2019s disease","volume":"11","author":"Garcia","year":"2022","journal-title":"Cells"},{"key":"B181","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/15476286.2019.1582956","article-title":"Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics","volume":"16","author":"Coenen-Stass","year":"2019","journal-title":"RNA Biol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13287-021-02151-w","article-title":"Exosomes derived from stem cells from apical papilla promote craniofacial soft tissue regeneration by enhancing Cdc42-mediated vascularization","volume":"12","author":"Liu","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000001744","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma","volume":"84","author":"Potter","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2022.114199","article-title":"Mesenchymal stromal cell secretome for traumatic brain injury: Focus on immunomodulatory action","volume":"357","author":"Pischiutta","year":"2022","journal-title":"Exp Neurol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40635-023-00535-1","article-title":"MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial","volume":"11","author":"Zanier","year":"2023","journal-title":"Intensive Care Med Exp"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13081159","article-title":"Mesenchymal stromal cells perspective: New potential therapeutic for the treatment of neurological diseases","volume":"13","author":"Mukai","year":"2021","journal-title":"Pharmaceutics"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105681","article-title":"Neurological efficacy and safety of mesenchymal stem cells (MSCs) therapy in people with multiple sclerosis (pwMS): An updated systematic review and meta-analysis","volume":"87","author":"Vaheb","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1290-8","article-title":"Mesenchymal stem cells secretome: A new paradigm for central nervous system regeneration","volume":"70","author":"Teixeira","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00249","article-title":"Mesenchymal stem cells secretome as a modulator of the neurogenic niche: Basic insights and therapeutic opportunities","volume":"9","author":"Salgado","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2013.06.020","article-title":"The stem cell secretome and its role in brain repair","volume":"95","author":"Drago","year":"2013","journal-title":"Biochimie"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-025-00733-6","article-title":"Emerging role of neural stem\/progenitor cell secretome in brain inflammatory response modulation","volume":"77","author":"\u0141ukowicz","year":"2025","journal-title":"Pharmacol Rep"},{"key":"B192","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1038\/s41598-017-03592-1","article-title":"Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF","volume":"7","author":"Martins","year":"2017","journal-title":"Sci Rep"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-1570-x","article-title":"Secretome of mesenchymal stem cells and its potential protective effects on brain pathologies","volume":"56","author":"Baez-Jurado","year":"2019","journal-title":"Mol Neurobiol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00064-21","article-title":"Mesenchymal stromal cells: an antimicrobial and host-directed therapy for complex infectious diseases","volume":"34","author":"Shaw","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1096\/fba.2022-00071","article-title":"Bone marrow-derived extracellular vesicles modulate the abundance of infiltrating immune cells in the brain and exert an antiviral effect against the Japanese encephalitis virus","volume":"4","author":"Soni","year":"2022","journal-title":"FASEB Bioadv"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq467","article-title":"Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis","volume":"32","author":"Van Linthout","year":"2011","journal-title":"Eur Heart J"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15378","article-title":"Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK\/mTOR-mediated autophagy flux pathway","volume":"24","author":"Gu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1779346","article-title":"Preconditioning and engineering strategies for improving the efficacy of mesenchymal stem cell-derived exosomes in cell-free therapy","volume":"2022","author":"Chen","year":"2022","journal-title":"Stem Cells Int"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.3390\/v16040619","article-title":"Mesenchymal stem cell-derived exosomes attenuate murine cytomegalovirus-infected pneumonia via NF-\u03baB\/NLRP3 signaling pathway","volume":"16","author":"Chen","year":"2024","journal-title":"Viruses"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.18821\/0507-4088-2018-63-6-261-267","article-title":"Mesenchymal stem cells enhance immune response and protectmice against lethal herpes viral infection","volume":"63","author":"Klimova","year":"2018","journal-title":"Probl Virol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1134\/S0026893321020242","article-title":"Preventive vaccination with mesenchymal stem cells protects mice from lethal infection caused by herpes simplex virus 1","volume":"55","author":"Klimova","year":"2021","journal-title":"Mol Biol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/860950","article-title":"Mesenchymal stromal cells and viral infection","volume":"2015","author":"Thanunchai","year":"2015","journal-title":"Stem Cells Int"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02816","article-title":"The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3\/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation","volume":"10","author":"Heinze","year":"2019","journal-title":"Front Immunol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.38207\/jcmphr\/2024\/mar05040332","article-title":"Human wharton-jelly- mesenchymal stem cells microvesicles and exosomes as potential antiviral activity against herpes simplex type 2","volume":"5","author":"Al-Daim","year":"2024","journal-title":"J Community Med Public Health Rep"},{"key":"B206","doi-asserted-by":"publisher","first-page":"14702","DOI":"10.1038\/s41598-018-32657-y","article-title":"Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NF\u03baB signaling pathway","volume":"8","author":"Chandra","year":"2018","journal-title":"Sci Rep"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5628404","article-title":"Exosomes and exosomal miRNA in respiratory diseases","volume":"2016","author":"Alipoor","year":"2016","journal-title":"Mediators Inflammation"},{"key":"B208","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1465-9921-15-39","article-title":"Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: A randomized, placebo-controlled pilot study","volume":"15","author":"Zheng","year":"2014","journal-title":"Respir Res"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202305-0865OC","article-title":"Intravenous autologous bone marrow\u2013derived mesenchymal stromal cells delay acute respiratory distress syndrome in swine","volume":"208","author":"Batchinsky","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-206813","article-title":"Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat","volume":"70","author":"Devaney","year":"2015","journal-title":"Thorax"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05026-w","article-title":"Exploring exosome-based approaches for early diagnosis and treatment of neurodegenerative diseases","author":"Varshney","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1007\/s13770-014-0072-1","article-title":"Crosstalk between mesenchymal stem cells and macrophages in tissue repair","volume":"11","author":"Chung","year":"2014","journal-title":"Tissue Eng Regener Med"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10040409","article-title":"Molecular mechanisms responsible for mesenchymal stem cell-based treatment of viral diseases","volume":"10","author":"Harrell","year":"2021","journal-title":"Pathogens"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1374","article-title":"Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential","volume":"43","author":"Volarevic","year":"2017","journal-title":"BioFactors"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0348","article-title":"Exosomal microRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis C virus infection","volume":"5","author":"Qian","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"B216","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/biom14010008","article-title":"Mesenchymal stem cell-based therapies in the post-acute neurological COVID syndrome: current landscape and opportunities","volume":"14","author":"Le\u00f3n-Moreno","year":"2024","journal-title":"Biomolecules"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-021-10224-9","article-title":"Multipotent stromal cells and viral interaction: current implications for therapy","volume":"18","author":"Taechangam","year":"2022","journal-title":"Stem Cell Rev Rep"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101860","article-title":"Growing evidence supporting the use of mesenchymal stem cell therapies in multiple sclerosis: A systematic review","volume":"38","author":"Oliveira","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B219","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","article-title":"Stem cell-based therapy for human diseases","volume":"7","author":"Hoang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B220","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41392-021-00488-5","article-title":"Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"6","author":"Shi","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103789","article-title":"Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Shi","year":"2022","journal-title":"EBioMedicine"},{"key":"B222","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13287-025-04148-1","article-title":"Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Yuan","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104600","article-title":"Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial","volume":"92","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"B224","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5336\/medsci.2021-85395","article-title":"Mesenchymal stem cell therapy in COVID-19 pneumonia: A prospective, randomized clinical research","volume":"42","author":"\u015eahin","year":"2022","journal-title":"Turkiye Klinikleri J Med Sci"},{"key":"B225","doi-asserted-by":"publisher","first-page":"9636897211024942","DOI":"10.1177\/09636897211024942","article-title":"The systematic effect of mesenchymal stem cell therapy in critical COVID-19 patients: A prospective double controlled trial","volume":"30","author":"Adas","year":"2021","journal-title":"Cell Transplant"},{"key":"B226","article-title":"Promising benefit of single mesenchymal stem cell injection in critically ill COVID-19 patients \u2013 A pilot phase randomized controlled study","volume":"11","author":"von Schwarz","year":"2011","journal-title":"Online Int Interdiscip Res J"},{"key":"B227","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13287-022-02812-4","article-title":"Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Karyana","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112920","article-title":"Advanced cell therapy with low tissue factor loaded product NestaCell\u00ae does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients","volume":"149","author":"Araldi","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0472","article-title":"Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1\/2a, randomized controlled trial","volume":"10","author":"Lanzoni","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"B230","doi-asserted-by":"publisher","first-page":"143","DOI":"10.12688\/f1000research.75580.2","article-title":"Effectiveness and safety profile of mesenchymal stem cell secretome as a treatment for severe cases of COVID-19: a randomized controlled trial","volume":"11","author":"Abdullah","year":"2022","journal-title":"F1000Res"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2024.2327478","article-title":"The effect of mesenchymal stem cells administration on DNA repair gene expressions in critically ill COVID-19 patients: prospective controlled study","volume":"43","author":"I\u015f\u0131ksa\u00e7an","year":"2024","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.25298\/2221-8785-2023-21-5-466-476","article-title":"Clinical efficacy of the application of pooled mesenchimal stem cells of the olfactory lining for the treatment of patients with severe community-acquired pneumonia complicated by acute respiratory distress syndrome","volume":"21","author":"Hancharou","year":"2023","journal-title":"J Grodno State Med Univ"},{"key":"B233","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13287-022-02771-w","article-title":"Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II","volume":"13","author":"Fathi-Kazerooni","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B234","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/S1465324921002796","article-title":"Results of the cellular immuno-therapy for covid-19 related acute respiratory distress syndrome (circa-phase i trial","volume":"23","author":"English","year":"2021","journal-title":"Cytotherapy"},{"key":"B235","doi-asserted-by":"publisher","first-page":"TP314","DOI":"10.1183\/23120541.LSC-2025.TP314","article-title":"Mesenchymal stromal cells may improve outcomes in severe COVID-19 related ARDS by normalizing SARS-CoV2-related lymphopenia","volume":"11","author":"Stewart","year":"2025","journal-title":"Trans Sci Eur Respir Soc"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1321303","article-title":"Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: a randomized controlled trial","volume":"10","author":"de Dios","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B237","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13287-022-02900-5","article-title":"Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study","volume":"13","author":"Zhu","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1224865","article-title":"Efficacy of Wharton Jelly Mesenchymal Stromal Cells infusions in moderate to severe SARS-Cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial","volume":"10","author":"Pochon","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B239","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13054-022-03930-4","article-title":"Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial","volume":"26","author":"Monsel","year":"2022","journal-title":"Crit Care"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.06.024","article-title":"Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for the treatment of respiratory failure from COVID-19","volume":"164","author":"Lightner","year":"2023","journal-title":"Chest"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03522-1","article-title":"Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program","volume":"14","author":"Vij","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"B242","doi-asserted-by":"publisher","first-page":"19","DOI":"10.23868\/202205004","article-title":"Safety and efficiency of inhalation method for administration of small extracellular vesicles derived from multipotent mesenchymal stromal cells of human umbilical cord in SARS- CoV-2 associated pneumonia","volume":"17","author":"Tiumina","year":"2022","journal-title":"Genes Cells"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2015.0074","article-title":"Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis","volume":"26","author":"Kantarcioglu","year":"2015","journal-title":"Turkish J Gastroenterol"},{"key":"B244","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4130757","article-title":"Combination treatments of plasma exchange and umbilical cord-derived mesenchymal stem cell transplantation for patients with hepatitis B virus-related acute-on-chronic liver failure: A clinical trial in China","volume":"2019","author":"Xu","year":"2019","journal-title":"Stem Cells Int"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0213","article-title":"Mesenchymal stromal cells in human immunodeficiency virus-infected patients with discordant immune response: Early results of a phase I\/II clinical trial","volume":"10","author":"Trujillo-Rodr\u00edguez","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"B246","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-021-00607-2","article-title":"Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29189","article-title":"Allogeneic bone marrow\u2013derived mesenchymal stromal cells for hepatitis B virus\u2013related acute-on-chronic liver failure: A randomized controlled trial","volume":"66","author":"Lin","year":"2017","journal-title":"Hepatology"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.4172\/2161-1025.1000173","article-title":"The strategy of combining antiviral agent, plasma exchange and transarterial mesenchymal stem cell transfusion in a patient with hepatitis B virus (HBV) related acute-on-chronic liver failure","volume":"6","author":"Li","year":"2016","journal-title":"Trans Med"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-016-9683-3","article-title":"Umbilical cord-derived mesenchymal stem cell transplantation in hepatitis B virus related acute-on-chronic liver failure treated with plasma exchange and entecavir: a 24-month prospective study","volume":"12","author":"Li","year":"2016","journal-title":"Stem Cell Rev Rep"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.12747","article-title":"Mesenchymal stem cell application in children with subacute sclerosing panencephalitis","volume":"57","author":"Ku\u015fkonmaz","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23148038","article-title":"Perivascular mesenchymal stem\/stromal cells, an immune privileged niche for viruses","volume":"23","author":"Lebeau","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2017.03.076","article-title":"Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy","volume":"19","author":"de Wolf","year":"2017","journal-title":"Cytotherapy"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2024.06.001","article-title":"Optimizing mesenchymal stem cell extracellular vesicles for chronic wound healing: Bioengineering, standardization, and safety","volume":"26","author":"Shimizu","year":"2024","journal-title":"Regener Ther"},{"key":"B254","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3324\/haematol.10669","article-title":"Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD\/SCID mice","volume":"92","author":"Shi","year":"2007","journal-title":"Haematologica"},{"key":"B255","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jtcvs.2007.07.071","article-title":"Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis","volume":"135","author":"Hu","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B256","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4252\/wjsc.v15.i11.999","article-title":"Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells","volume":"15","author":"Li","year":"2023","journal-title":"World J Stem Cells"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.7150\/thno.51631","article-title":"The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential","volume":"11","author":"Contreras-Lopez","year":"2021","journal-title":"Theranostics"},{"key":"B258","doi-asserted-by":"publisher","DOI":"10.3390\/cells12182262","article-title":"TNF-\u03b1 Preconditioning improves the therapeutic efficacy of mesenchymal stem cells in an experimental model of atherosclerosis","volume":"12","author":"Sekenova","year":"2023","journal-title":"Cells"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102243","article-title":"Preconditioning of mesenchymal stem cells enhances the neuroprotective effects of their conditioned medium in an Alzheimer\u2019s disease in vitro model","volume":"12","author":"Tolstova","year":"2024","journal-title":"Biomedicines"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.09.009","article-title":"CRISPR\/Cas9 genome-editing system in human stem cells: current status and future prospects","volume":"9","author":"Zhang","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.01.022","article-title":"CRISPR interference efficiently induces specific and reversible gene silencing in human iPSCs","volume":"18","author":"Mandegar","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-016-0360-8","article-title":"An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells","volume":"8","author":"Guo","year":"2017","journal-title":"Protein Cell"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092281","article-title":"Recent advances in extracellular vesicle-based therapies using induced pluripotent stem cell-derived mesenchymal stromal cells","volume":"10","author":"Bertolino","year":"2022","journal-title":"Biomedicines"},{"key":"B264","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14974","article-title":"Heparan sulfate proteoglycan-mediated dynamin-dependent transport of neural stem cell exosomes in an in vitro blood\u2013brain barrier model","volume":"53","author":"Joshi","year":"2021","journal-title":"Eur J Neurosci"},{"key":"B265","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41551-018-0325-8","article-title":"Manufacturing of primed mesenchymal stromal cells for therapy","volume":"3","author":"Yin","year":"2019","journal-title":"Nat BioMed Eng"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119403","article-title":"IFN-\u03b3-tethered hydrogels enhance mesenchymal stem cell-based immunomodulation and promote tissue repair","volume":"220","author":"Garc\u00eda","year":"2019","journal-title":"Biomaterials"},{"key":"B267","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s13287-024-03935-6","article-title":"How to enhance MSCs therapeutic properties? An insight on potentiation methods","volume":"15","author":"Garc\u00eda-Guerrero","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B268","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijcard.2015.03.425","article-title":"Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction","volume":"188","author":"Liu","year":"2015","journal-title":"Int J Cardiol"},{"key":"B269","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13287-017-0553-y","article-title":"Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid","volume":"8","author":"Killer","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"B270","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba6884","article-title":"Shattering barriers toward clinically meaningful MSC therapies","volume":"6","author":"Levy","year":"2020","journal-title":"Sci Adv"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11110552","article-title":"Principal criteria for evaluating the quality, safety and efficacy of hMSC-based products in clinical practice: current approaches and challenges","volume":"11","author":"Guadix","year":"2019","journal-title":"Pharmaceutics"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914800","article-title":"Mesenchymal stem cells in the treatment of COVID-19","volume":"24","author":"Guo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1428652","article-title":"The evolution of mesenchymal stem cell-derived neural progenitor therapy for Multiple Sclerosis: from concept to clinic","volume":"18","author":"Ghareghani","year":"2024","journal-title":"Front Cell Neurosci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677433\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:29:41Z","timestamp":1761715781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677433\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":273,"alternative-id":["10.3389\/fimmu.2025.1677433"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1677433","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1677433"}}